$10,000 Becomes $2,586 in One Year: The Hidden Decay Engine Inside UVXY

If you bought ProShares Ultra VIX Short-Term Futures ETF (CBOE:UVXY) a year ago hoping to ride the next panic, your account tells the story the marketing won’t. A $10,000 stake on June 23, 2025 is worth roughly $2,586 today. The VIX itself, the thing UVXY is supposed to track, sits at a perfectly ordinary 17.28. The fear gauge barely moved. Your money evaporated anyway.

What You’re Actually Paying

The sticker price first. UVXY carries a 0.95% expense ratio. On a $10,000 position, that is $95 a year skimmed off the top, every year, regardless of what volatility does. Compound that over 10 years against a broad index fund charging 0.03% and the fee gap alone runs into the high hundreds of dollars. But the expense ratio is the cheapest cost in this product.

The real bill is structural. UVXY is a 1.5x leveraged daily reset product holding short-term VIX futures. Daily reset means leverage is recalculated every session, so volatile chop quietly grinds the share price down even when the VIX ends the month flat. Layer on contango (the persistent cost of rolling near-month futures into pricier later-month futures) and the decay becomes mechanical, not bad luck.

The receipts: down 22.27% year to date, down 74.14% over one year, down 99.6% over five years, and effectively 100% over ten years. Since inception in 2011, the split-adjusted price has fallen from over $2.4 million per share to single digits. One analyst flatly called the fund’s behavior a “self-destructive nature caused by leveraged compounding and volatility cycles.”

The Part the Factsheet Doesn’t Highlight

There are three costs ProShares is not advertising on the front page.

First, reverse splits. UVXY executed a 1-for-5 reverse stock split on November 20, 2025. Reverse splits don’t lose you money on paper, but they exist because the share price keeps collapsing. They reset the optics so the chart looks tradable again. Your dollar exposure to the decay engine is unchanged.

Second, what you actually own. According to fund disclosures on March 20, 2026, UVXY’s holdings were 100% U.S. Dollar, roughly $364 million. The VIX exposure lives in swaps and futures contracts off the holdings table. You are paying 0.95% for a basket of cash plus derivative bets whose roll cost you cannot see on a screen.

Third, institutional warning shots. Vanguard banned individual clients from trading roughly 400 leveraged and inverse products in 2019, including this category, calling them “generally incompatible with a buy-and-hold strategy.” ProShares itself cut leverage on UVXY in February 2018 after a volatility spike decimated peer products. When the issuer has to de-risk its own fund to keep it alive, that is a structural cost.

The Cheaper Mirror

If the goal is volatility exposure, the unleveraged sibling VIXY tracks the same S&P 500 VIX Short-Term Futures Index at 1x instead of 1.5x. Same contango drag, but without the leverage-decay multiplier. For a true hedge, listed VIX call options or S&P 500 put options let you size a defined-risk position without paying a daily reset tax in perpetuity. None of these are free, and all carry their own friction. The point is that the 1.5x daily-rebalanced wrapper is the most expensive way to express the trade.

What This Means for You

UVXY is a stopwatch, not a savings account. It can spike hard during a panic (the VIX touched 31.05 on March 27, 2026) and reward a trader who is in for days. The question worth asking before you click buy: do you have a defined exit, or are you holding a product whose own designers describe as “designed for short-term trading rather than long-term investment”? If the answer is the latter, the 0.95% fee is the least of what this fund quietly charges you.